| Literature DB >> 27871246 |
Nicole Werner1, Melissa Gómez1, Marcelo Baeza1, Víctor Cifuentes1, Jennifer Alcaíno2.
Abstract
BACKGROUND: The basidiomycetous yeast Xanthophyllomyces dendrorhous has been described as a potential biofactory for terpenoid-derived compounds due to its ability to synthesize astaxanthin. Functional knowledge of the genes involved in terpenoid synthesis would create opportunities to enhance carotenoid production. A thiolase enzyme catalyzes the first step in terpenoid synthesis.Entities:
Keywords: Astaxanthin; Carotenoids; Functional complementation; Mevalonate; Sterols; Thiolase
Mesh:
Substances:
Year: 2016 PMID: 27871246 PMCID: PMC5117609 DOI: 10.1186/s12866-016-0893-2
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Phylogenetic tree of ERG10A and ERG10B thiolases from X. dendrorhous compared to other organisms. The unrooted tree was created in MEGA 6.0 using the neighbor-joining method [20] with the following amino acid sequences. Mitochondrial thiolase/acetyl-CoA C-acetyltransferase: B. taurus [NP_001039540.1], H. sapiens [BAA01387.1], C. lupus familiaris [XP_546539.2], R. norvegicus [NP_058771.2], G. gallus [NP_001264708.1]. Cytoplasmic thiolase/acetyl-CoA C-acetyltransferase: S. pombe [Q9UQW6.1], B. graminis f. sp. tritici 96224 [EPQ61678.1], S. cerevisiae [P41338.3], N. tabacum [AAU95618.1], Z. mays [NP_001266315.1], A. thaliana [Q9FIK7.1]. Mitochondrial thiolase/3-ketoacyl-CoA thiolase: B. taurus [NP_001030419.1], M. musculus [NP_803421.1], R. norvegicus [NP_569117.1]. Peroxisomal thiolase/3-ketoacyl-CoA thiolase: S. cerevisiae [CAA37472.1], Y. lipolytica [Q05493.1], G. gallus [NP_001184217.1], M. musculus [NP_570934.1], E. caballus [XP_001488609.1], C. lupus familiaris [XP_534222.2]. B. taurus [NP_001029491.1], H. sapiens [NP_001598.1]. X. dendrorhous [ERG10A]: thiolase encoded by the ERG10A gene. X. dendrorhous [ERG10B]: thiolase encoded by the ERG10B gene. Accession numbers are given in parentheses. Numbers at each node indicate the percentage support for a specific node after 1,000-replica bootstrap analysis
Fig. 2ERG10A and ERG10B relative transcript levels. a In strain 385-cyp61 (−/−), which does not produce ergosterol. Level of change was determined by comparison to wild type UCD 67–385 (control). Cultures were grown in YM liquid media for 24 h (blue) or 120 h (red). Each bar represents an average of three independent cultures. Black lines indicate standard deviation. *p < 0.05, **p < 0.01. b Effect of glucose addition. Gene expression kinetics and glucose concentration were quantified in strain UCD 67–385 after adding glucose (20 g/l final concentration). Error bars correspond to the standard deviation (n = 3). The negative values on the y-axis denote decrease relative to control
Strains and plasmids used in this work
| Strain/Plasmid | Genotype or relevant features | Reference |
|---|---|---|
| Strain: | ||
|
| ||
| UCD 67–385 | Wild type, diploid strain. | ATCC 24230 |
| 385- | Homozygote transformant derived from UCD 67–385 with both | [ |
| 385- | Heterozygous mutant of UCD 67–385 with one allele of | This work |
| 385- | Heterozygous mutant of UCD 67–385 with one allele of | This work |
| 385- | Homozygous mutant of UCD 67–385 with both | This work |
| 385- | Heterozygote transformant derived from UCD 67–385 containing an additional | This work |
| 385- | Heterozygote transformant derived from UCD 67–385 containing an additional | This work |
| 385-Vexp2 | Heterozygote transformant derived from UCD 67–385 containing an empty over-expressing cassette (without an inserted ORF) and a hygromycin B resistance cassette integrated at | This work |
|
| ||
| s288C |
| [ |
| ATCC 4022800 (Sc-ERG10/erg10) |
| [ |
| Sc-ERG10sc | Strain Sc-ERG10/erg10 carrying plasmid YEpNP-10sc. | This work |
| Sc-cERG10xd | Strain Sc-ERG10/erg10 carrying plasmid YEpNP-c10Xd. | This work |
| Sc-cPOT1xd | Strain Sc-ERG10/erg10 carrying plasmid YEpNP-cPOT1Xd. | This work |
| Plasmid: | ||
| pBluescript SK- (pBS) | ColE1 replication origin, AmpR, LacZ for blue-white colony screening. | Stratagene |
| pBS-PT-ERG10xd | pBS with 620 bp of DNA upstream of | This work |
| pBS-PT-POT1xd | pBS with 559 bp of DNA upstream of | This work |
| pMN- | Plasmid containing an hygromycin B resistance cassette for | [ |
| pPHT-Erg10xd | pBS -PT-ERG10Xd with a hygromycin B resistance cassette in the | This work |
| pPHT-POT1xd | pBS-PT-POT1Xd with a hygromycin B resistance cassette in the | This work |
| pPZT-Erg10xd | pBS-PT-ERG10Xd with a zeocin resistance cassette in the | This work |
| YEp-ACT4 | pBR322 and 2 micron replication origins, AmpR, | [ |
| YEp-NP | YEpACT4 with a | [ |
| YEpNP-10sc | YEp-NP with | This work |
| YEpNP-c10xd | YEp-NP with | This work |
| YEpNP-cPOT1xd | YEp-NP with | This work |
| pXdVexp2 |
| [ |
| pXdVexp2-c | pXdVexp2 containing the cDNA version of the | This work |
| pXdVexp2-c | pXdVexp2 containing the cDNA version of the | This work |
Fig. 3PCR analyses of S. cerevisiae haploid strains. S. cerevisiae strains Sc-ERG10sc (carrying plasmid YEpNP-10sc) and Sc-cERG10xd (carrying plasmid YEpNP-c10xd) were analyzed by PCR to confirm the expected genotype. As controls, X. dendrorhous UCD 67–385 strain (Lane 1), S. cerevisiae strain S288c (Lane 2), S. cerevisiae diploid strain Sc-ERG10/erg10 (Lane 3) and a no-template control (Lane 6), were included. S. cerevisiae Sc-ERG10sc haploid strain (Lane 4) and S. cerevisiae Sc-cERG10xd haploid strain (Lane 5) were analyzed to assess: a absence of chromosomal ERG10 from S. cerevisiae (primers erg10scF and erg10scDWR); b presence of geneticin resistance cassette in S. cerevisiae (primers KanMXF2 and KanMXR2); c presence of ERG10 from S. cerevisiae (primers erg10scF and erg10scR); and d presence of ERG10 from X. dendrorhous (primers Thio2Fw and Thio2Rv). The molecular size markers Lambda DNA/HindIII (Lane M; 23.1, 9.4, 6.6, 4.4, 2.3, 2 and 0.6 kb) and GeneRuler 1 kb Plus (Lane 1kB, band size in kb is indicated) were used. On the right side of the picture, a schematic diagram of the amplification products is included; arrows represent primer sets with a letter indicating in which panel they were used. UP and DOWN (in blue) correspond to chromosomal regions located approximately 300 bp upstream and downstream of the S. cerevisiae ERG10 gene, respectively, KanMX4 corresponds to the geneticin (G418) resistance module, and pACT4 (in red) and tTDH3 (in green) correspond to promoter and terminator regions in the vector YEpNP, respectively
Total sterol and carotenoid content in X. dendrorhous POT1 mutant strains
| Strain | UCD 67–385 | 385- | 385- |
|---|---|---|---|
| Total Sterols (mg/g dry weight) | 5.7 ± 0.3 | 4.6 ± 0.2 | 5.6 ± 0.6 |
| Total Carotenoids (μg/g dry weight) | 207.8 ± 21.5 | 201.5 ± 3.8 | 174 ± 19.5 |
| % Astaxanthin | 82.0 ± 3.4 | 78.6 ± 0.7 | 49.4* ± 2.4 |
| % Beta-carotene | 2.3 ± 0.7 | 2.8 ± 0.1 | 10.0* ± 0.8 |
| % Phoenicoxanthin | 8.0 ± 1.3 | 9.9 ± 0.4 | 16.5* ± 0.6 |
| % Other carotenoids | 7.7 ± 1.7 | 8.6 ± 0.3 | 23.0* ± 2.0 |
Each value corresponds to the average of three independent samples ± standard deviation. Other carotenoids include hydroxy-keto-γ-carotene, hydroxy-equinenone, hydroxy-keto-torulene and canthaxanthin. *p < 0.01, Student’s T-test compared to wild type
Fig. 4Changes in transcript levels for POT1 mutant strains. Relative transcript levels of genes POT1, ERG10, crtS and crtR of X. dendrorhous were analyzed in samples obtained after 96 h of growth in liquid YM media for strains UCD 67–385, 385-pot1 (+/−) and 385-pot1 (−/−). The results were analyzed using the 2-ΔΔCt method using actin as the normalizer gene and UCD 67–385 as the control strain compared to 385-pot1 (+/−) (blue) and 385-pot1 (−/−) (red). For POT1 transcript analysis in strain 385-pot1 (−/−), no transcript was detected. Each bar represents an average of three independent samples. Black lines indicate standard deviation. *p < 0.01
Total sterol and carotenoid contents in X. dendrorhous thiolase overexpression strains
| Strain | UCD 67–385 | 385-Vexp2 | 385- | 385- |
|---|---|---|---|---|
| Gene overexpression (−fold compared to control) | N/A | 1.0 (0.9–1.1) | 4.9*(3.7–6.4) | 3.2*(2.2–4.7) |
| Total sterols (mg/g dry weight) | 3.5 ± 0.4 | 3.8 ± 0.1 | 3.9 ± 0.2 | 3.9 ± 0.1 |
| Total carotenoids (μg/g dry weight) | 359.0 ± 16.3 | 401.7 ± 26.8 | 394.1 ± 15.9 | 349.7 ± 24.8 |
| % Astaxanthin | 75.4 ± 1.2 | 74.4 ± 0.2 | 68.7 ± 2.0 | 73.8 ± 1.4 |
| % Beta-carotene | 2.8 ± 0.7 | 2.6 ± 0.1 | 4.1 ± 0.9 | 2.8 ± 0.4 |
| % Phoenicoxanthin | 11.6 ± 0.3 | 10.8 ± 0.7 | 12.2 ± 0.6 | 10.9 ± 0.6 |
Each value corresponds to the average value of three independent samples ± standard deviation. Overexpression data are presented as an average with standard deviation in parentheses. The relative expression of the studied genes in 385-Vexp2 was compared to wild type strain UCD 67–385, and the results indicated no significant differences in the relative expression of these genes; therefore, relative expression for each gene in the overexpression mutants was compared to control strain 385-Vexp2. N/A = Not Analyzed. *p < 0.01, Student’s T-test